The Latest Cardiac and Vascular News
Medicalgorithmics has received FDA approval in the U.S. for its proprietary next generation system in ECG signal analysis called DeepRhytmAI. WARSAW, Poland, Aug. 10, 2022 /PRNewswire/ — It is a cloud-based Artificial Intelligence algorithm that classifies ECG signals. Without excessive human involvement, DeepRhytmAI […]
The US Food and Drug Administration has registered Qpatch, an ECG wearable unit developed by experts from Medicalgorithmics. The FDA approval allows use of ECG readings from Qpatch in the United States. WARSAW, Poland, June 9, 2022 /PRNewswire/ — Qpatch is a state-of-the-art […]
PLANO, Texas, July 23, 2018 /PRNewswire/ — MEDICALgorithmics, S.A. (WSE: MDG) and U.S. subsidiary Medi-Lynx Cardiac Monitoring L.L.C., today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the PocketECG Cardiac Rehabilitation System (CRS), a new mobile […]
BOSTON, May 2, 2018 /PRNewswire/ — Medicalgorithmics, S.A. (WSE: MDG) today announced the presentation of a large study evaluating online vs offline ECG monitoring methods to diagnose paroxysmal atrial fibrillation (AF), often difficult to detect because of its episodic nature. Research will be […]
